Eli Lilly and Company has reported positive topline results from its Phase 3 ACHIEVE-2 and ACHIEVE-5 clinical trials evaluating orforglipron in adults with type 2 diabetes
The pharmaceutical market is under growing pres¬sure as governments all over the world tighten reg¬ulation and enforcement. The presence of frequent quality audits and non-conformance citations is a serious threat and usually leads to operational hal
Rehan Khan, Managing Director of MSD India, shares that India has more unicorn startups than billion-dollar drugs. Despite a huge patient pool with diabetes, hypertension, and cancer, the country has yet to deliver a homegrown therapy crossing $1 bil
Healthium Medtech, a global medical technology company with an expanding portfolio spanning surgical, post-surgical, advanced wound care, arthroscopy, and infection prevention, has entered into an exclusive partnership with Tisgenx, Inc.—a U.S.-based
Maverick Simulation Solutions, a frontrunner in the field of advanced medical simulation technology, has achieved a significant milestone by installing India’s first Anatomage Table at Vardhman Mahavir Medical College (VMMC) and Safdarjung Hospital
The Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with the Serum Institute of India (SII) Pvt. Ltd. the world’s largest vaccine manufacturer and part of the Cyrus Poonawalla Group to strengthen global pandemic preparedness
Aurobindo Pharma's promoter group has successfully secured around 2,000 crore with a dual-tranche financing structure intended for platform acquisitions, which includes the Taj Banjara asset situated in Hyderabad. The funds are being directed
Cadila Pharmaceuticals, one of the leading research-based pharmaceutical companies in India, has now launched Dlorfast-M Tablets. It is a new fixed-dose combination tablet that contains 5 mg of Desloratadine (a novel antihistamine) and 10 mg...
Orbital Therapeutics, a privately held biotech company, was purchased by Bristol Myers Squibb (BMS) for $1.5 billion in cash. The agreement, which was made public on October 10, 2025, gives BMS access to Orbital's exclusive RNA-based platform and
From December 19 to 21, 2025, the 21st PharmaTech Expo & LabTech Expo will be held at the Bengaluru International Exhibition Centre (BIEC), Bengaluru, in conjunction with the Contract Manufacturing and Raw & Packaging Material Expo. Professionals
.jpg)
, CDSCO.jpg)